Research and Clinical Trials

Title  
LCI-LUN-NSC-SBRT-001: Phase II Prospective Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy followed by concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer
Brief Description  
To determine the one-year progression-free survival rate, progression-free survival, overall survival, and toxicity of subjects with locally-advanced non-small cell lung cancer treated with stereotactic body radiation therapy followed by concurrent mediastinal chemoradiation with either proton therapy or photon therapy.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Lung
Status  
OPEN
Start Date  
05/11/2017
IRB Number  
00021247
Principal Investigator  
Heinzerling, John Henry
Contact Name  
Jenna Scalesse

For More Information, Contact  Jenna  , Scalesse
Phone:  704-403-1520 Fax:    
Email:  Jenna.Gregory@carolinashealthcare.org
Address:100 Medical Park Drive Suite 110 Concord, 28025
Close